This study aims to evaluate the effectiveness of conventional metabolic parameters and radiomic features from 18F-deoxyglucose(FDG) PET in predicting Ki-67 expression status in patients with non-Hodgkin’s lymphoma. This evidence concerns the gene MKI67 and non-Hodgkin lymphoma.